Trend of Helicobacter pylori Infection in Childhood: A Single-Center Experience

Abdulkerim Elmas1, Mustafa Akçam1

  • 1Department of Pediatrics, Süleyman Demirel University, School of Medicine, Isparta, Turkey.

PubMed

Insights

Helicobacter pylori (HP) infection prevalence in children and adolescents significantly decreased between 2007 and 2022. Positivity rates were higher in older children and linked to duodenal ulcers.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Epidemiology

Background:

  • Helicobacter pylori (HP) is a common bacterial infection, with prevalence increasing with age.
  • HP infection rates in Turkish children range from 30% to 56.6%, varying regionally.

Purpose of the Study:

  • To determine the frequency of HP infection in pediatric patients undergoing upper gastrointestinal endoscopy.
  • To analyze trends in HP infection rates over time in a specific region.
  • To compare HP prevalence across different age groups and its association with duodenal ulcers.

Main Methods:

  • Retrospective analysis of clinical and endoscopic data from 1737 pediatric cases (2007-2022).
  • Diagnosis confirmed via histopathologic examination of gastric biopsy specimens for HP presence.
  • Statistical analysis to assess trends and associations.

Main Results:

  • Overall HP positivity was 29% (504/1737 cases).
  • HP positivity increased with age: 14.5% (0-6 yrs), 26.9% (7-12 yrs), 33.6% (13-18 yrs).
  • Significant association between HP positivity and duodenal ulcers (65.7% of duodenal ulcer patients were HP positive).
  • HP positivity rates decreased significantly over the study period: 44% (2007-2012), 28.6% (2013-2017), 24.2% (2018-2022).

Conclusions:

  • The frequency of Helicobacter pylori infection in children and adolescents has decreased in the studied region over 15 years.
  • Higher HP prevalence in older children suggests age-related risk factors.
  • Decreasing trends may correlate with increased awareness and socioeconomic development.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
335
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
101
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
161
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
546
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
292
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
358